CD4 and relapsing-remitting multiple sclerosis: It has been shown that there is a significant decrease in the number of CD4+Foxp3+ T cells as well as the expression level of Foxp3 in relapsing-remitting MS and other lymphoproliferative autoimmune disorders [7], [9], [34].